Advances in the development of new tuberculosis drugs and treatment regimens
San Francisco General Hospital · University of California, San Francisco · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
879
total citations
- FWCI
- 60.06
- Percentile
- 100%
- References
- 130
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Ethambutol
- Pyrazinamide
- Medicine
- Tuberculosis
- Rifampicin
- Clinical trial
- Intensive care medicine
- Drug
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.